MicroRNA-138: A Diagnostic Biomarker and Therapeutic Target for the Aggressive Basal-like subtype of Breast Cancer

ABSTRACT: This study identifies miR-138 as a prognostic biomarker for basal breast carcinoma. Identification of differentially regulated genes upon miR-138 knockdown (AntagomiR-138) in basal breast cancer cell lines MDA-MB-231

ORGANISM(S): Homo sapiens

PROVIDER: GSE110659 | GEO | 2020/04/13

REPOSITORIES: GEO